Study: NCT00699153

Adverse event: Blocked arteries
Serious: yes
Organ System: Cardiac disorders
Notes: One subject had 2 events of blocked arteries
Frequency: 2 affected / 204 at risk

Adverse event: Diabetic foot
Serious: yes
Organ System: Endocrine disorders
Frequency: 1 affected / 204 at risk

Adverse event: Fall/Hip fracture
Serious: yes
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 204 at risk

Adverse event: Pituitary tumor
Serious: yes
Organ System: Endocrine disorders
Frequency: 1 affected / 204 at risk

Adverse event: Anterior chamber inflammation
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs Related to Study Drug in Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 49 affected / 204 at risk

Adverse event: Eye pain
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs \>/= 5% in Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 7 affected / 204 at risk

Adverse event: Corneal oedema
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 10 affected / 204 at risk

Adverse event: Conjunctival hyperaemia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 6 affected / 204 at risk

Adverse event: Ciliary hyperaemia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 5 affected / 204 at risk

Adverse event: Photophobia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 5 affected / 204 at risk

Adverse event: Iritis
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 4 affected / 204 at risk

Adverse event: Uveitis
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 4 affected / 204 at risk

Adverse event: Blocked arteries
Serious: yes
Organ System: Cardiac disorders
Notes: One subject had 2 events of blocked arteries
Frequency: 2 affected / 201 at risk

Adverse event: Diabetic foot
Serious: yes
Organ System: Endocrine disorders
Frequency: 1 affected / 201 at risk

Adverse event: Fall/Hip fracture
Serious: yes
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 2 affected / 201 at risk

Adverse event: Pituitary tumor
Serious: yes
Organ System: Endocrine disorders
Frequency: 1 affected / 201 at risk

Adverse event: Anterior chamber inflammation
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs Related to Study Drug in Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 94 affected / 201 at risk

Adverse event: Eye pain
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs \>/= 5% in Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 17 affected / 201 at risk

Adverse event: Corneal oedema
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 12 affected / 201 at risk

Adverse event: Conjunctival hyperaemia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 15 affected / 201 at risk

Adverse event: Ciliary hyperaemia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 13 affected / 201 at risk

Adverse event: Photophobia
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 12 affected / 201 at risk

Adverse event: Iritis
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 12 affected / 201 at risk

Adverse event: Uveitis
Serious: no
Organ System: Eye disorders
Notes: Ocular TEAEs in \>/= 5% of Study Eyes, Either Treatment Group, Prior to Rescue Medication Use - Safety Population
Frequency: 10 affected / 201 at risk